Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MONARCH 1: Abemaciclib Monotherapy in HR+/HER2- Metastatic Breast Cancer
NCT02102490Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of abemaciclib in breast cancer, sponsored by Eli Lilly and Company. Started Jun 2014; status: completed.
02
Drugs
abemaciclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02102490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02102490.